MedPath

Galderma Brasil Ltda.

🇧🇷Brazil
Ownership
Subsidiary
Employees
-
Market Cap
-
Website
http://www.galderma.com.br

Clinical Trials

6

Active:0
Completed:5

Trial Phases

3 Phases

Phase 3:1
Phase 4:3
Not Applicable:1

Drug Approvals

1

PHILIPPINES:1

Drug Approvals

Differin

Approval Date
Jul 14, 2025
PHILIPPINES

Clinical Trials

Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials

Phase 4
3 (60.0%)
Not Applicable
1 (20.0%)
Phase 3
1 (20.0%)

Retrospective Study of the Safety and Efficacy of PLLA for Skin Flaccidity in Labia Majora and/or Pubis Region

Recruiting
Conditions
Skin Laxity
First Posted Date
2023-07-11
Last Posted Date
2023-10-30
Lead Sponsor
Galderma Brasil Ltda.
Target Recruit Count
10
Registration Number
NCT05940038
Locations
🇧🇷

Clínica Hexsel de Dermatologia, Porto Alegre, Rio Grande Do Sul, Brazil

Efficacy and Safety of Poly-L-lactic Acid

Not Applicable
Completed
Conditions
Flaccidity, Muscle
First Posted Date
2017-07-21
Last Posted Date
2018-03-29
Lead Sponsor
Galderma Brasil Ltda.
Target Recruit Count
70
Registration Number
NCT03225066
Locations
🇧🇷

Centro Brasileiro de Estudos em Dermatologia, Porto Alegre, RS, Brazil

🇧🇷

Fundação do ABC, São Paulo, SP, Brazil

🇧🇷

Hospital Israelita Albert Einstin, São Paulo, SP, Brazil

and more 1 locations

A Multicenter, Open-label Clinical Trial to Evaluate the Efficacy and Safety of Once Daily Mirvaso® Gel in Patients With Chronic Persistent Vascular Facial Erythema.

Phase 4
Completed
Conditions
Chronic Persistent Vascular Facial Erythema
Interventions
First Posted Date
2016-08-05
Last Posted Date
2017-04-06
Lead Sponsor
Galderma Brasil Ltda.
Target Recruit Count
101
Registration Number
NCT02856919
Locations
🇧🇷

Instituto de Dermatologia e Estética do Brasil Ltda, Rio de Janeiro, RJ, Brazil

🇧🇷

Centro Brasileiro de Estudos em Dermatologia, Porto Alegre - RS, RS, Brazil

🇧🇷

Clinica Drmatologica Dra. Laura Buratini Ltda., Botucatu, SP, Brazil

and more 2 locations

A Comparative Study of Adapalene Gel,0.3% Versus Tretinoin Emollient Cream, 0.05% for the Treatment of Photoaging

Phase 3
Completed
Conditions
Photoaging
Photodamage
Interventions
First Posted Date
2011-07-29
Last Posted Date
2017-04-06
Lead Sponsor
Galderma Brasil Ltda.
Target Recruit Count
128
Registration Number
NCT01406080
Locations
🇧🇷

Centro de Dermatologia Dona Libania, Fortaleza, Ceará, Brazil

🇧🇷

Santa Casa de Belo Horizonte, Belo Horizonte, Minas Gerais, Brazil

🇧🇷

Hospital de Clínicas da Universidade Federal do Paraná, Curitiba, Paraná, Brazil

and more 1 locations

Evaluation of Efficacy and Safety of Adapalene 0.1%/Benzoyl Peroxide 2.5% Gel in the Treatment of Acne Vulgaris

Phase 4
Completed
Conditions
Acne Vulgaris
Interventions
Drug: Adapalene-BPO Gel
First Posted Date
2010-06-23
Last Posted Date
2012-03-12
Lead Sponsor
Galderma Brasil Ltda.
Target Recruit Count
75
Registration Number
NCT01149330
Locations
🇧🇷

Serviço de Dermatologia do Ambulatório Magalhães Neto do Complexo HUPES - Universidade Federal da Bahia, Salvador, Bahia, Brazil

🇧🇷

Instituo da Pele, Goiania, Goias, Brazil

🇧🇷

Hospital De Clínicas - Universidade Federal do Paraná, Curitiba, Paraná, Brazil

and more 3 locations
  • Prev
  • 1
  • 2
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.